Tag: MORT
GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D
No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA versus DPP4i users
A-Fib Linked to Worse Outcomes for Patients With Heart Failure, MR Undergoing Valve Repair
Increase in primary end point of death, heart failure hospitalization seen in association with baseline AF for patients undergoing M-TEER
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs
Similar Reduction Seen in Mortality for Exercise Patterns in Diabetes
Weekend warrior and regular activity patterns meeting current recommendations associated with reduced all-cause, CVD mortality
ENDO: Osteoporosis Treatment Benefits Elderly Patients With Fragility Fracture
Benefits include lower incidence of all-cause mortality, hospitalizations
Risk for Death From Prostate Cancer Low With Guideline Care for Nonmetastatic Disease
Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to six times more likely to die of other causes
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
Consistently and increasingly active individuals have lower risks for all-cause, CVD mortality
Stratifying BMI by Waist Circumference Improves Mortality Risk Prediction in Postmenopausal Women
Researchers say clinical guidelines for assessing adiposity would benefit from incorporation of BMI-specific WC thresholds
Living in Marginalized Neighborhoods Linked to Adverse Outcomes in Acute MI
Increasing neighborhood marginalization linked to higher rates of mortality beginning at 30 days after discharge
Uterine Cancer Incidence, Mortality Expected to Increase Through 2050
Incidence-based mortality projected to be nearly three times higher in Black versus White women
